SEOUL, Feb. 22 (Korea Bizwire) — South Korea’s leading botox maker Hugel Inc. said Tuesday its botulinum toxin product, Letybo, has won approval from Austrian drug authorities. The Austrian Federal Office for Safety in Health Care granted the use of Letybo for the treatment of frown lines in adult patients. It marks the first time [...]
SEOUL, Oct. 29 (Korea Bizwire) — A U.S. trade panel has invalidated its final ruling that sided with South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain dispute, company officials here said Friday. In December last year, the U.S. International Trade Commission (ITC) ordered a 21-month ban [...]
SEOUL, June 18 (Korea Bizwire) — South Korea’s drug safety watchdog said Thursday it has decided to revoke the permit of the country’s first botulinum toxin products by Medytox for using an unapproved ingredient and fabricating related documents. The three Meditoxin products — which come in bottles of 50 units, 100 units and 150 units [...]